29.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$29.92
Offen:
$29.87
24-Stunden-Volumen:
3.51M
Relative Volume:
0.85
Marktkapitalisierung:
$16.28B
Einnahmen:
$11.89B
Nettoeinkommen (Verlust:
$-560.00M
KGV:
-27.09
EPS:
-1.1
Netto-Cashflow:
$191.00M
1W Leistung:
-5.10%
1M Leistung:
-5.87%
6M Leistung:
+3.08%
1J Leistung:
-11.65%
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BAX
Baxter International Inc
|
29.80 | 16.28B | 11.89B | -560.00M | 191.00M | -1.10 |
![]()
ISRG
Intuitive Surgical Inc
|
509.49 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
168.59 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
84.77 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
250.88 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
217.95 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-26 | Fortgesetzt | Goldman | Buy |
2025-02-24 | Hochstufung | Argus | Hold → Buy |
2025-02-20 | Fortgesetzt | Barclays | Overweight |
2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2024-05-30 | Eingeleitet | Goldman | Neutral |
2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2023-03-29 | Eingeleitet | UBS | Neutral |
2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
2022-10-18 | Eingeleitet | Barclays | Overweight |
2022-10-12 | Eingeleitet | Jefferies | Hold |
2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
2022-02-18 | Bestätigt | Raymond James | Outperform |
2022-02-18 | Bestätigt | Stifel | Buy |
2022-02-18 | Bestätigt | UBS | Neutral |
2022-02-18 | Bestätigt | Wells Fargo | Overweight |
2022-02-11 | Eingeleitet | Goldman | Neutral |
2022-01-07 | Fortgesetzt | Citigroup | Buy |
2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
2021-05-25 | Eingeleitet | Barclays | Equal Weight |
2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-01-06 | Herabstufung | UBS | Buy → Neutral |
2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
2020-09-04 | Herabstufung | Argus | Buy → Hold |
2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
2020-03-19 | Hochstufung | Stifel | Hold → Buy |
2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-05 | Eingeleitet | Citigroup | Neutral |
2020-02-13 | Eingeleitet | Goldman | Buy |
2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
2018-11-02 | Hochstufung | Argus | Hold → Buy |
2018-10-16 | Eingeleitet | Barclays | Underweight |
2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
2018-02-06 | Bestätigt | Citigroup | Neutral |
2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
UBS Affirms Neutral Rating on Baxter International (BAX) - MSN
BAXTER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Baxter International In - The Globe and Mail
Tobam Lowers Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Cut to Hold at Wall Street Zen - MarketBeat
Baxter International Inc. (NYSE:BAX) Shares Purchased by SG Americas Securities LLC - MarketBeat
Baxter International Inc. (NYSE:BAX) Shares Bought by Handelsbanken Fonder AB - MarketBeat
Baxter International Inc. (NYSE:BAX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Bard Financial Services Inc. Acquires Shares of 28,090 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Sees Unusually High Options Volume (NYSE:BAX) - MarketBeat
Baxter International (BAX) Announces Amended Credit Agreements - GuruFocus
José Almeida: 100 Most Influential People in Healthcare 2024 - Modern Healthcare
Baxter secures $2.2 billion credit agreement By Investing.com - Investing.com South Africa
Baxter International Amends Credit and Loan Agreements - TipRanks
Baxter International Enters Amended And Restated Five-Year Credit AgreementSEC Filing - MarketScreener
Baxter stock holds Neutral rating at UBS amid CEO transition questions - Investing.com
Transcript : Baxter International Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener
GAMMA Investing LLC Has $13.27 Million Stock Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com
Baxter International To Present At Goldman Sachs Global Conference; Webcast At 10:40 AM ET - Nasdaq
Baxter recalls Novum pump linked to 1 serious injury - MedTech Dive
Baxter issues serious correction for large-volume infusion pump - MassDevice
Baxter International Inc. (BAX) Stock Analysis: Navigating Uncertain Waters with a 26.71% Upside Potential - DirectorsTalk Interviews
Baxter International Inc. (NYSE:BAX) Sees Large Decrease in Short Interest - MarketBeat
Rhumbline Advisers Buys 99,846 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Baxter International Inc. (BAX) - ACCESS Newswire
Baxter International (BAX) Rebounded in Q1 After Reporting Strong Earnings - Insider Monkey
Baxter partners with Pieces for AI care solutions - Yahoo
Baxter to Offer Pieces' AI Platform to Hospital Care Teams - PR Newswire
174,950 Shares in Baxter International Inc. (NYSE:BAX) Bought by Public Employees Retirement System of Ohio - MarketBeat
Baxter Bros Inc. Sells 1,796 Shares of Honeywell International Inc. (NASDAQ:HON) - MarketBeat
Baxter International Inc. (NYSE:BAX) Shares Sold by California State Teachers Retirement System - MarketBeat
Baxter spinoff Vantive plans $1 billion R&D push in kidney care - Crain's Chicago Business
Vantive, Baxter's former kidney care unit, to invest $1B in tech - Modern Healthcare
Baxter International Inc (BAX) Stock Price Down 3.18% on Jun 2 - GuruFocus
Goldman Sachs Adjusts Price Target on Baxter International to $37 From $39, Maintains Buy Rating - marketscreener.com
Industrial-grade hydrogen peroxide leak causes evacuation at Baxter Healthcare in Round Lake; no injuries reported - Lake and McHenry County Scanner
GF Fund Management CO. LTD. Buys Shares of 12,513 Baxter International Inc. (NYSE:BAX) - MarketBeat
Canada Clinical Nutrition Market Is Booming WorldwideBaxter, B. Braun Melsungen - openPR.com
Baxter International (BAX) Traded Higher Despite Tariff Disruptions - Insider Monkey
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):